GCP
CUE icon

GSA Capital Partners’s Cue Biopharma CUE Stock Holding History

GSA Capital Partners’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Buy
+678
New +$6.33K ﹤0.01% 1663
2025
Q2 		– Sell
-3,909
Closed -$107K – 1803
2025
Q1 		$107K Sell
3,909
-1,084
-22% -$40.3K 0.01% 1488
2024
Q4 		$163K Sell
4,993
-4,729
-49% -$178K 0.01% 1459
2024
Q3 		$221K Buy
9,722
+470
+5% +$10.2K 0.02% 1376
2024
Q2 		$344K Buy
9,252
+2,282
+33% +$113K 0.02% 1193
2024
Q1 		$395K Buy
6,970
+6,505
+1,399% +$459K 0.03% 1045
2023
Q4 		$37K Buy
+465
New +$33.2K ﹤0.01% 1426
2023
Q3 		– Sell
-609
Closed -$67K – 1560
2023
Q2 		$67K Sell
609
-1,828
-75% -$215K 0.01% 1408
2023
Q1 		$261K Sell
2,437
-3,840
-61% -$366K 0.03% 1110
2022
Q4 		$537K Sell
6,277
-931
-13% -$85.1K 0.07% 561
2022
Q3 		$482K Buy
7,208
+2,886
+67% +$248K 0.06% 592
2022
Q2 		$323K Buy
4,322
+1,103
+34% +$129K 0.05% 776
2022
Q1 		$471K Sell
3,219
-108
-3% -$22.9K 0.06% 575
2021
Q4 		$1.13M Sell
3,327
-731
-18% -$283K 0.14% 151
2021
Q3 		$1.77M Buy
4,058
+3,111
+329% +$1.09M 0.18% 88
2021
Q2 		$331K Buy
947
+525
+124% +$203K 0.04% 890
2021
Q1 		$155K Sell
422
-1,721
-80% -$708K 0.03% 951
2020
Q4 		$804K Buy
2,143
+650
+44% +$260K 0.13% 196
2020
Q3 		$674K Buy
+1,493
New +$860K 0.11% 249

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

GSA Capital Partners's CUE Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Cue Biopharma (CUE) in Q1 2026: 678 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1663 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in CUE as recently as Q1 2025.

GSA Capital Partners first reported a position in CUE in Q3 2020 and has held it in 19 quarters since. The position peaked at $1.77M in Q3 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • GSA Capital Partners held 678 shares of Cue Biopharma worth $5K as of Q1 2026.
  • Cue Biopharma was a new GSA Capital Partners position in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1663 holding.
  • GSA Capital Partners first reported a position in Cue Biopharma in Q3 2020 and has held it in 19 quarters since.
  • GSA Capital Partners's Cue Biopharma position peaked at $1.77M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.